Table 5.
Effect of absence of staff, HIV testing commodities and PMTCT drugs on monthly MCH consultations in all clinics, post-intervention
| N | OR | P value | |
|---|---|---|---|
|
Absence of MCH staff | |||
| HIV-exposed infants starting follow-up visits |
67 |
0.20 |
0.200 |
| Any HIV tests in HIV-exposed infants |
69 |
0.06 |
0.027 |
| Serologic HIV tests in HIV-exposed infants |
69 |
0.10 |
0.030 |
|
Absence of testing supplies | |||
| Pregnant women detected as HIV+ |
70 |
0.48 |
0.166 |
| Any HIV tests in HIV-exposed infants |
70 |
0.90 |
0.812 |
| Serologic HIV tests in HIV-exposed infants |
70 |
0.56 |
0.201 |
|
Absence of MCH drugs | |||
| HIV + pregnant women initiating PMTCT |
69 |
0.56 |
0.463 |
| HIV + women receiving PMTCT during childbirth |
69 |
0.32 |
0.196 |
| HIV-exposed infants receiving PMTCT at birth | 69 | 0.32 | 0.193 |